12月5日晚间,智飞生物(300122.SZ)就该公司与葛兰素史克(GSK)的一项《独家经销和联合推广协议》的部分条款变更进行公告,修订协议削减了交易的总金额,并延长了协议期限。12月6日收盘,智飞生物股价上涨约4.5%。去年10月,智飞生物获得GSK带状疱疹疫苗(商品名:欣安立适)在中国大陆地区独家进口、分销和共同推广的权利。该疫苗于2019年在中国获批,用于预防50岁及以上成年人的带状疱疹。...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.